RNA Therapeutics: From Base Pairs to Bedside

Worcester, Umass, 28-29 June 2018

Marie Lindholm, Head of Technology Innovation, will be presenting


European Hematology Association (EHA)

Stockholm, Sweden, 14-17 June 2018

Ute Schaeper, Discovery Research Project Leader, presented


2018 Bio International Convention

Boston, MA, 4-7 June 2018



Boston, MA, 7-10 May 2018

Torsten Hoffmann, CSO, will be presenting


9th Clinical Trials Innovation Programme

Frankfurt, Germany, 26-27 April 2018

Torsten Hoffmann, CSO, will be presenting


Oligo 2018

Oxford, UK, 10 April 2018

Adrien Weingaertner, Group Leader, Drug Delivery, presented


Rare Disease Symposium at OPT Congress

Boston, MA, 28 March 2018

Torsten Hoffmann, COO, presented and appeared as a panelist


Oligonucleotide & Peptide Therapeutics (OPT)

Boston, MA, 26-28 March 2018

Marie Lindholm, Head of Technology Innovation, presented


Cowen 38th Annual Health Care Conference

Boston, MA, 12-14 March 2018

Click here to register in advance for the live webcast.   A replay of the webcast will be available for 14 business days through the same link 

Presentation by Ali Mortazavi, CEO


Full Year Results 2017

London, UK, 6 March 2018



Kyoto, Japan, 27 February - 1 March 2018

Presentation by Torsten Hoffmann, COO

Afternoon session chaired by Torsten Hoffmann, COO


JP Morgan Healthcare Conference

San Francisco CA, 8-11 January 2018


14th International Conference on Thalassaemia & Haemoglobinopathies

Thessaloniki, Greece, 17-19 November 2017


Capital Markets Day

London, UK, 14 November 2017


5th Canton Nucleic Acids Forum (CNAF)

Guangzhou, China, 9-10 November 2017


17th Annual Biotech in Europe Forum

Basel, Switzerland, 26-27 September 2017


Canaccord Genuity 37th Annual Growth

Boston MA, 9-10 August 2017


TIDES: Oligonucleotide and peptide therapeutics

San Diego CA, 30 April – 3 May 2017



Antisense & Therapeutic Nucleic Acids

Oxford, UK, 10 April 2017


Oligonucleotide and Peptide Therapeutics

Boston MA, 26-29 March 2017


‘Therapeutic RNA delivery: into hepatocytes and beyond’


Kyoto, Japan, 21-23 February 2017


'Hepatic gene disruption in vivo after liposomal delivery of Cas9 mRNA and chemically modified guide RNAs’


Berlin, Germany, 14-16 November 2016